Learning about treatment effects in a new target population under transportability assumptions for relative effect measures.
Dahabreh IJ, Robertson SE, Steingrimsson JA.
Eur J Epidemiol. 2024 May 10. PMID: 38724763
Dahabreh IJ, Robertson SE, Steingrimsson JA.
Eur J Epidemiol. 2024 May 10. PMID: 38724763
Robertson SE, Steingrimsson JA, Dahabreh IJ.
Eval Rev. 2024 Dec. 48(6):1088-1114. PMID: 38234059
Robertson SE, Steingrimsson JA, Joyce NR, Stuart EA, Dahabreh IJ.
Am J Epidemiol. 2024 01 08. 193(1):149-158. PMID: 35225329
Robertson SE, Joyce NR, Steingrimsson JA, Stuart EA, Aberle DR, Gatsonis CA, Dahabreh IJ.
JAMA Netw Open. 2024 01 02. 7(1):e2346295. PMID: 38289605
Joyce NR, Robertson SE, McCreedy E, Ogarek J, Davidson EH, Mor V, Gravenstein S, Dahabreh IJ.
Clin Trials. 2023 12. 20(6):613-623. PMID: 37493171
Dahabreh IJ, Robins JM, Haneuse SJA, Saeed I, Robertson SE, Stuart EA, Hernán MA.
Stat Med. 2023 06 15. 42(13):2029-2043. PMID: 36847107
Dahabreh IJ, Robertson SE, Petito LC, Hernán MA, Steingrimsson JA.
Biometrics. 2023 06. 79(2):1057-1072. PMID: 35789478
Robertson SE, Steingrimsson JA, Dahabreh IJ.
Eur J Epidemiol. 2023 Feb. 38(2):123-133. PMID: 36626100
Aggarwal R, Yeh RW, Dahabreh IJ, Robertson SE, Wadhera RK.
PLoS Med. 2022 10. 19(10):e1004083. PMID: 36194574
Robertson SE, Steingrimsson JA, Dahabreh IJ.
Am J Epidemiol. 2022 09 28. 191(10):1834-1835. PMID: 35513350